Amarin Vascepa box
Pharma

Amarin sells Vascepa's rights in Europe to Recordati for $25M

Amarin has forged a potentially $175 million deal with Recordati to commercialize Vascepa in Europe.
Kevin Dunleavy Jun 24, 2025 11:26am
Data analysis insights through simple conversations how ciATHENA is transforming life sciences commercial analytics

Data analysis & insights through simple conversations: how ciATHENA is transforming life sciences commercial analytics

Jun 23, 2025 8:00am
Bill Cassidy and RFK Jr

Cassidy calls for deferral of CDC's vaccine meeting

Jun 24, 2025 10:40am
Elevating Data Quality in CNS Trials Through Thoughtful Use of eCOA

Elevating Data Quality in CNS Trials Through Thoughtful Use of eCOA

Jun 23, 2025 8:00am
London England

The Bloc expands into UK with new London office, executive hires

Jun 24, 2025 10:27am
The World Cant Wait Delivering on the Promise of Biopharmas Golden Age Mina Makar Senior Vice President Global

Delivering on the Promise of Biopharma’s “Golden Age"

Jun 23, 2025 8:00am
More News

Regulatory tracker: GSK wins pediatric nod for lupus autoinjector

Jun 24, 2025 10:15am

Craig Romanok takes up chief commercial officer post at Digitas

Jun 24, 2025 9:45am

FDA signs off on AZ, Daiichi's Datroway for EGFR-mutated NSCLC

Jun 24, 2025 8:10am

UK reveals life sciences plan in sweeping strategy update

Jun 23, 2025 3:55pm